FDA
approval
· 2022-03-30
FDA Approved: IOFLUPANE I 123 — Original Application (Curium US LLC)
Summary
The FDA approved IOFLUPANE I-123 (IOFLUPANE I-123) from Curium US LLC in an Original Application as a dopamine transporter imaging agent for SPECT to help evalu…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for IOFLUPANE I 123 (IOFLUPANE I-123)